Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Perdan-Pirkmajer

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Rheumatology|December 18, 2025
Diagnostic potential of soluble and membrane-bound inducible T-cell co-stimulator in Sjögren's diseaseNeža Štucin, Katja Perdan Pirkmajer, Alojzija Hočevar, et al.
International Journal of Molecular Sciences|April 30, 2021
Adiponectin Deregulation in Systemic Autoimmune Rheumatic DiseasesNeža Brezovec, Katja Perdan-Pirkmajer, Saša Čučnik, et al.
International Journal of Molecular Sciences|February 26, 2022
Increased L-Selectin on Monocytes Is Linked to the Autoantibody Profile in Systemic SclerosisNeža Brezovec, Katja Perdan-Pirkmajer, Tadeja Kuret, et al.
Frontiers in Immunology|February 12, 2021
COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic DiseasesKatja Lakota, Katja Perdan-Pirkmajer, Alojzija Hočevar, et al.
Clinical Rheumatology|August 4, 2018
The incidence rate and the early management of rheumatoid arthritis in SloveniaRok Ješe, Katja Perdan-Pirkmajer, Alojzija Hočevar, et al.
Rheumatology International|September 8, 2012
Tumour necrosis factor-alpha inhibitor-induced hepatic injury in patients with rheumatoid arthritis: two case reports and an analysis of the laboratory data from the Slovenian national biologicals registryKatja Perdan-Pirkmajer, Alojzija Hočevar, Žiga Rotar, et al.
Biomedicines|August 27, 2021
The Predictive Value of the aCL and Anti-β2GPI at the Time of Acute Deep Vein Thrombosis-A Two-Year Prospective StudyKatja Perdan-Pirkmajer, Polona Žigon, Anja Boc, et al.
Journal of Immunology Research|June 17, 2015
Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy OutcomesPolona Žigon, Katja Perdan Pirkmajer, Matija Tomšič, et al.
Biomedicines|August 26, 2023
Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal SymptomsNeža Brezovec, Katja Perdan-Pirkmajer, Blaž Burja, et al.
Frontiers in Physiology|October 26, 2020
Ouabain Suppresses IL-6/STAT3 Signaling and Promotes Cytokine Secretion in Cultured Skeletal Muscle CellsSergej Pirkmajer, Katja Bezjak, Urška Matkovič, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Rheumatology|December 18, 2025
Diagnostic potential of soluble and membrane-bound inducible T-cell co-stimulator in Sjögren's diseaseNeža Štucin, Katja Perdan Pirkmajer, Alojzija Hočevar, et al.
International Journal of Molecular Sciences|April 30, 2021
Adiponectin Deregulation in Systemic Autoimmune Rheumatic DiseasesNeža Brezovec, Katja Perdan-Pirkmajer, Saša Čučnik, et al.
International Journal of Molecular Sciences|February 26, 2022
Increased L-Selectin on Monocytes Is Linked to the Autoantibody Profile in Systemic SclerosisNeža Brezovec, Katja Perdan-Pirkmajer, Tadeja Kuret, et al.
Frontiers in Immunology|February 12, 2021
COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic DiseasesKatja Lakota, Katja Perdan-Pirkmajer, Alojzija Hočevar, et al.
Clinical Rheumatology|August 4, 2018
The incidence rate and the early management of rheumatoid arthritis in SloveniaRok Ješe, Katja Perdan-Pirkmajer, Alojzija Hočevar, et al.
Rheumatology International|September 8, 2012
Tumour necrosis factor-alpha inhibitor-induced hepatic injury in patients with rheumatoid arthritis: two case reports and an analysis of the laboratory data from the Slovenian national biologicals registryKatja Perdan-Pirkmajer, Alojzija Hočevar, Žiga Rotar, et al.
Biomedicines|August 27, 2021
The Predictive Value of the aCL and Anti-β2GPI at the Time of Acute Deep Vein Thrombosis-A Two-Year Prospective StudyKatja Perdan-Pirkmajer, Polona Žigon, Anja Boc, et al.
Journal of Immunology Research|June 17, 2015
Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy OutcomesPolona Žigon, Katja Perdan Pirkmajer, Matija Tomšič, et al.
Biomedicines|August 26, 2023
Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal SymptomsNeža Brezovec, Katja Perdan-Pirkmajer, Blaž Burja, et al.
Frontiers in Physiology|October 26, 2020
Ouabain Suppresses IL-6/STAT3 Signaling and Promotes Cytokine Secretion in Cultured Skeletal Muscle CellsSergej Pirkmajer, Katja Bezjak, Urška Matkovič, et al.
Pageof 4